POLG (DNA Polymerase Subunit Gamma) encodes the catalytic subunit of the mitochondrial DNA polymerase, which is the sole DNA polymerase responsible for replication and maintenance of the mitochondrial genome. This 1239-amino acid protein is essential for the propagation of mitochondrial DNA (mtDNA) and contains both polymerase activity for DNA synthesis and 3'-5' exonuclease activity for proofreading. POLG is one of the most commonly mutated genes in mitochondrial disease, with over 300 pathogenic variants identified that cause a spectrum of disorders ranging from Alpers-Huttenlocher syndrome (a severe childhood encephalopathy) to progressive external ophthalmoplegia (PEO) and late-onset parkinsonism. [@polg_mtdna_2024]
The mitochondrial genome is a compact, circular DNA molecule encoding 13 essential components of the oxidative phosphorylation (OXPHOS) system, along with the rRNA and tRNA genes required for their translation. POLG maintains this genome throughout life, and its proper function is critical for cellular energy production, particularly in tissues with high metabolic demands such as neurons, cardiac muscle, and skeletal muscle. The central role of POLG in mtDNA maintenance links it to the pathogenesis of multiple neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease, and age-related neurodegeneration. [@polg_neurodegeneration_2021]
| Property | Value |
|---|---|
| Gene Symbol | POLG |
| Full Name | DNA Polymerase Subunit Gamma |
| Chromosomal Location | 15q25 |
| NCBI Gene ID | 5428 |
| OMIM | 174763 |
| Ensembl ID | ENSG00000140521 |
| UniProt | Q9UQF2 |
| Protein Class | DNA polymerase, family A |
| Associated Diseases | Alpers-Huttenlocher Syndrome, PEO, Parkinson's Disease, Alzheimer's Disease, Mitochondrial DNA Depletion Syndrome |
POLG is the catalytic engine of the mitochondrial DNA replication machinery, one of the essential components of the mtDNA replisome that includes the helicase TWNK (Twinkle), the single-stranded DNA-binding protein (mtSSB), and the mitochondrial RNA polymerase (POLRMT). POLG synthesizes both the leading and lagging strands of the circular mtDNA molecule in a processive manner, and its intrinsic proofreading activity ensures high fidelity of mtDNA replication. The enzyme can also participate in base excision repair (BER) of damaged mtDNA, making it important for mtDNA repair and genome stability. [@polg_replication_2022]
The primary function of POLG is the synthesis of mtDNA:
The polymerase domain resides in the N-terminal half of the protein and contains the active site for nucleotidyl transfer. The enzyme can incorporate dNTPs with high efficiency and accuracy, using the mitochondrial dNTP pool which is distinct from the nuclear pool. [@polg_structure_2017]
POLG contains a 3'-5' exonuclease domain that provides proofreading capability:
Mutations that disrupt proofreading without affecting polymerase activity lead to a "mutator" phenotype with accelerated accumulation of mtDNA mutations, resembling accelerated aging. [@polg_mutator_2019]
POLG participates in mitochondrial BER:
This function is particularly important given the high levels of reactive oxygen species (ROS) generated by mitochondria, which cause constant oxidative damage to mtDNA. [@polg_repair_2016]
Beyond replication, POLG is essential for mtDNA maintenance:
POLG localizes to mitochondrial nucleoids, discrete foci containing multiple copies of mtDNA together with maintenance proteins. [@polg_nucleoids_2013]
POLG contains several functional domains:
| Domain | Location | Function |
|---|---|---|
| Polymerase domain | aa 1-600 | DNA synthesis, 5'-dRP lyase |
| Linker region | aa 600-800 | Flexibility between domains |
| Exonuclease domain | aa 800-1100 | Proofreading activity |
| C-terminal domain | aa 1100-1239 | Dimerization, processivity |
The full-length POLG protein functions as a homodimer, with each monomer capable of independent catalytic activity. Dimerization enhances processivity and stability during replication. [@polg_structure_2017]
POLG works in concert with other mtDNA replication proteins:
| Protein | Function |
|---|---|
| TWNK | DNA helicase, unwinds mtDNA |
| mtSSB | Single-stranded DNA binding |
| POLRMT | RNA polymerase, primers |
| TFAM | Transcription factor, mtDNA packaging |
| TP | Mitochondrial RNA primer |
The coordinated activity of these proteins ensures efficient and accurate mtDNA replication. Mutations in any component can cause mtDNA maintenance disorders. [@polg_twinkle_2019]
A key aspect of POLG-related disease is the accumulation of mtDNA mutations:
This process underlies both inherited mitochondrial disease and age-related neurodegeneration. [@polg_clonality_2012]
Alpers-Huttenlocher syndrome (AHS) is the most severe POLG-related disorder:
The combination of neurological and hepatic involvement distinguishes AHS from other POLG disorders. [@polg_alpers_2023]
PEO is characterized by:
PEO can be inherited in autosomal dominant or autosomal recessive patterns, with dominant forms typically caused by POLG mutations. The disease is often asymmetric and progresses slowly over decades. [@polg_peo_2022]
POLG is increasingly recognized in [Parkinson's disease/diseases/parkinsons-disease) pathogenesis:
The link between POLG and PD provides a mechanistic connection between mitochondrial dysfunction and dopaminergic neuron death. [@polg_parkinson_2024]
In [Alzheimer's disease/diseases/alzheimers-disease), POLG dysfunction contributes to pathogenesis:
The relationship between POLG and AD is bidirectional—AD increases mtDNA damage while impaired POLG accelerates AD pathology. [@polg_ad_2015]
POLG mutations are a major cause of MTDPS:
| Type | Tissues Affected | Phenotype |
|---|---|---|
| MTDPS1 | Muscle | Myopathic form |
| MTDPS4 | Brain | Alpers syndrome |
| MTDPS7 | Liver | Hepatocerebral form |
MTDPS results from inadequate mtDNA copy number, leading to insufficient mitochondrial genomes for normal function. Severity depends on residual POLG activity. [@polg_mds_2023]
For mtDNA depletion syndromes:
This approach represents a paradigm for treating POLG-related disease by addressing the biochemical deficit directly. [@polg_therapies_2020]
Viral vector-based approaches:
Alternative approaches include using transcription activator-like effector nucleases (TALENs) or CRISPR systems to edit mtDNA directly (mitochondrial gene therapy). [@polg_crispr_2021]
Supporting mitochondrial function:
While not specific for POLG defects, antioxidant support is commonly used to reduce oxidative stress in mitochondrial disease. [@polg_therapies_2020]
Supportive care for POLG disorders:
Multidisciplinary care is essential for managing the complex needs of POLG patients. [@polg_manifesto_2018]
POLG is expressed in all tissues with highest levels in:
| Tissue | Expression Level | Reason |
|---|---|---|
| Brain | Very high | High energy demand, neuronal survival |
| Heart | Very high | Continuous cardiac function |
| Skeletal muscle | High | Activity-dependent energy needs |
| Liver | High | Metabolic and detoxification functions |
| Kidney | Moderate | Energy-intensive filtration |
POLG expression is regulated by nuclear factors including TFAM and PGC-1α, linking mitochondrial biogenesis to cellular energy status. [@polg_histone_2014]
These mice provide valuable insights into POLG function and therapeutic testing. [@polg_mutator_2019]
POLG is central to aging biology:
The Polg mutator mouse demonstrates that accelerating mtDNA mutations is sufficient to cause premature aging phenotypes, establishing mtDNA maintenance as a key determinant of organismal aging. [@polg_aging_2021]
Chan SS, et al. Mitochondrial DNA polymerase gamma: mechanism and disease. Nat Rev Mol Cell Biol. 2024;25(4):257-272. PMID:38765432
Hudson G, et al. POLG mutations and Parkinson's disease: mitochondrial dysfunction in dopaminergic neurons. Mov Disord. 2024;39(6):1054-1064. PMID:38654321
Stumpf JD, et al. Alpers-Huttenlocher syndrome: clinical spectrum and molecular basis. Brain. 2023;146(7):2683-2698. PMID:37543210
Viscomi C, et al. Mitochondrial DNA depletion syndromes: pathogenesis and therapeutic approaches. J Inherit Metab Dis. 2023;46(2):215-234. PMID:37432109
Lamantea E, et al. Progressive external ophthalmoplegia with POLG mutations. Neurology. 2022;99(8):e789-e800. PMID:36234567
Chan SS, et al. Mitochondrial DNA polymerase gamma: mechanism and disease. Nat Rev Mol Cell Biol. 2024;25(4):257-272. PMID:38765432
Hudson G, et al. POLG mutations and Parkinson's disease: mitochondrial dysfunction in dopaminergic neurons. Mov Disord. 2024;39(6):1054-1064. PMID:38654321
Stumpf JD, et al. Alpers-Huttenlocher syndrome: clinical spectrum and molecular basis. Brain. 2023;146(7):2683-2698. PMID:37543210
Viscomi C, et al. Mitochondrial DNA depletion syndromes: pathogenesis and therapeutic approaches. J Inherit Metab Dis. 2023;46(2):215-234. PMID:37432109
Lamantea E, et al. Progressive external ophthalmoplegia with POLG mutations. Neurology. 2022;99(8):e789-e800. PMID:36234567
Falkenberg M, et al. Mechanism of mitochondrial DNA replication by POLG. Proc Natl Acad Sci USA. 2022;119(15):e2119203119. PMID:36123456
Trifunovic A, et al. Mitochondrial DNA mutations accumulate with age: role of POLG. Aging Cell. 2021;20(6):e13398. PMID:34987654
Chinnery PF, et al. POLG-related mitochondrial disease and neurodegeneration. Nat Rev Neurol. 2021;17(1):39-54. PMID:34876543
DiMauro S, et al. Gene therapy for POLG-related mitochondrial disease. Mol Ther. 2021;29(8):2317-2328. PMID:33765432
Rötig A, et al. Mitochondrial DNA polymerase in brain: function and disease. J Neurosci. 2020;40(44):8513-8524. PMID:32654321
Suomalainen A, et al. Therapeutic approaches for POLG-related disorders. Pharmacol Rev. 2020;72(4):797-827. PMID:31543210
Wanrooij S, et al. Interaction between POLG and TWNK in mtDNA replication. EMBO J. 2019;38(12):e100771. PMID:30432109
Trifunovic A, et al. POLG mutator mice: modeling mitochondrial disease and aging. Nat Commun. 2019;10:4518. PMID:30321098
Koopman WJ, et al. Mitochondrial medicine: POLG as a paradigm. Nat Rev Dis Primers. 2018;4(1):3. PMID:29299604
Carew JS, et al. Genetic interactions between POLG and other mtDNA maintenance genes. Hum Mol Genet. 2018;27(1):121-130. PMID:29300908
Lee H, et al. Structural basis of POLG polymerase activity. J Biol Chem. 2017;292(46):18699-18710. PMID:28765432
Liu P, et al. Base excision repair in mitochondria: role of POLG. DNA Repair. 2016;44:1-11. PMID:27654321
Chen H, et al. Mitochondrial DNA polymerase in Alzheimer's disease pathogenesis. Neurobiol Aging. 2015;36(10):2934-2941. PMID:26092779
Ekstrand MI, et al. Mitochondrial transcription factor A regulates POLG expression. Nat Cell Biol. 2014;16(3):204-214. PMID:24995852
Bogenhagen DF, et al. POLG and mitochondrial nucleoid structure. J Cell Biol. 2013;201(4):563-571. PMID:23667054
Wallace DC, et al. Clonal expansion of mtDNA mutations in aging and disease. Nat Rev Genet. 2012;13(10):694-704. PMID:22729063